162 related articles for article (PubMed ID: 38385332)
21. Design, structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives/analogues.
Sahu PK
Eur J Med Chem; 2016 Oct; 121():510-516. PubMed ID: 27318975
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
Wang R; Zhang X; Chen C; Chen G; Zhong Q; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2016 Mar; 110():164-80. PubMed ID: 26827161
[TBL] [Abstract][Full Text] [Related]
23. Curcumin Analog CH-5 Suppresses the Proliferation, Migration, and Invasion of the Human Gastric Cancer Cell Line HGC-27.
Silva G; Teixeira Lima F; Seba V; Mendes Lourenço AL; Lucas TG; de Andrade BV; Torrezan GS; Polaquini CR; Garcia ME; Couto LB; Bestetti RB; de Castro França S; Fachin AL; Regasini LO; Marins M
Molecules; 2018 Jan; 23(2):. PubMed ID: 29385675
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationship studies of curcumin analogues.
Fuchs JR; Pandit B; Bhasin D; Etter JP; Regan N; Abdelhamid D; Li C; Lin J; Li PK
Bioorg Med Chem Lett; 2009 Apr; 19(7):2065-9. PubMed ID: 19249204
[TBL] [Abstract][Full Text] [Related]
25. Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.
Ohtsu H; Xiao Z; Ishida J; Nagai M; Wang HK; Itokawa H; Su CY; Shih C; Chiang T; Chang E; Lee Y; Tsai MY; Chang C; Lee KH
J Med Chem; 2002 Nov; 45(23):5037-42. PubMed ID: 12408714
[TBL] [Abstract][Full Text] [Related]
26. Diarylpentanoids with antitumor activity: A critical review of structure-activity relationship studies.
Moreira J; Saraiva L; Pinto MM; Cidade H
Eur J Med Chem; 2020 Apr; 192():112177. PubMed ID: 32172081
[TBL] [Abstract][Full Text] [Related]
27. Potent anti-cancer effects of less polar Curcumin analogues on gastric adenocarcinoma and esophageal squamous cell carcinoma cells.
Alibeiki F; Jafari N; Karimi M; Peeri Dogaheh H
Sci Rep; 2017 May; 7(1):2559. PubMed ID: 28566729
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents.
Samaan N; Zhong Q; Fernandez J; Chen G; Hussain AM; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2014 Mar; 75():123-31. PubMed ID: 24531225
[TBL] [Abstract][Full Text] [Related]
29. Arylnitro monocarbonyl curcumin analogues: Synthesis and in vitro antitubercular evaluation.
du Preez C; Legoabe LJ; Jordaan A; Jesumoroti OJ; Warner DF; Beteck RM
Chem Biol Drug Des; 2023 Mar; 101(3):717-726. PubMed ID: 36350112
[TBL] [Abstract][Full Text] [Related]
30. Antiproliferative efficacy of curcumin mimics through microtubule destabilization.
Khwaja S; Fatima K; Hasanain M; Behera C; Kour A; Singh A; Luqman S; Sarkar J; Chanda D; Shanker K; Gupta AK; Mondhe DM; Negi AS
Eur J Med Chem; 2018 May; 151():51-61. PubMed ID: 29605808
[TBL] [Abstract][Full Text] [Related]
31. 3D-QSAR and Molecular Docking Studies on Design Anti-Prostate Cancer Curcumin Analogues.
Meng X; Cui L; Song F; Luan M; Ji J; Si H; Duan Y; Zhai H
Curr Comput Aided Drug Des; 2020; 16(3):245-256. PubMed ID: 30370853
[TBL] [Abstract][Full Text] [Related]
32. Discovery and evaluation of asymmetrical monocarbonyl analogs of curcumin as anti-inflammatory agents.
Zhang Y; Zhao C; He W; Wang Z; Fang Q; Xiao B; Liu Z; Liang G; Yang S
Drug Des Devel Ther; 2014; 8():373-82. PubMed ID: 24741294
[TBL] [Abstract][Full Text] [Related]
33. Synthetic and Medicinal Prospective of Structurally Modified Curcumins.
Kumar B; Singh V; Shankar R; Kumar K; Rawal RK
Curr Top Med Chem; 2017; 17(2):148-161. PubMed ID: 27280465
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
Ramya PVS; Guntuku L; Angapelly S; Digwal CS; Lakshmi UJ; Sigalapalli DK; Babu BN; Naidu VGM; Kamal A
Eur J Med Chem; 2018 Jan; 143():216-231. PubMed ID: 29174816
[TBL] [Abstract][Full Text] [Related]
35. A Review: Exploring Synthetic Schemes and Structure-activity Relationship (SAR) Studies of Mono-carbonyl Curcumin Analogues for Cytotoxicity Inhibitory Anticancer Activity.
Bhandari SV; Kuthe P; Patil SM; Nagras O; Sarkate AP
Curr Org Synth; 2023; 20(8):821-837. PubMed ID: 36703591
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of allylated and prenylated mono-carbonyl analogs of curcumin as anti-inflammatory agents.
Liu Z; Tang L; Zou P; Zhang Y; Wang Z; Fang Q; Jiang L; Chen G; Xu Z; Zhang H; Liang G
Eur J Med Chem; 2014 Mar; 74():671-82. PubMed ID: 24321865
[TBL] [Abstract][Full Text] [Related]
37. Curcumin analogues and derivatives with anti-proliferative and anti-inflammatory activity: Structural characteristics and molecular targets.
Chainoglou E; Hadjipavlou-Litina D
Expert Opin Drug Discov; 2019 Aug; 14(8):821-842. PubMed ID: 31094233
[No Abstract] [Full Text] [Related]
38. Synthesis and evaluation of a series of novel asymmetrical curcumin analogs for the treatment of inflammation.
Zhang Y; Zhao L; Wu J; Jiang X; Dong L; Xu F; Zou P; Dai Y; Shan X; Yang S; Liang G
Molecules; 2014 Jun; 19(6):7287-307. PubMed ID: 24901832
[TBL] [Abstract][Full Text] [Related]
39. 4-Bromo-4'-chloro pyrazoline analog of curcumin augmented anticancer activity against human cervical cancer, HeLa cells:
Chaudhary M; Kumar N; Baldi A; Chandra R; Babu MA; Madan J
J Biomol Struct Dyn; 2020 Mar; 38(5):1335-1353. PubMed ID: 30957694
[TBL] [Abstract][Full Text] [Related]
40. A novel monocarbonyl analogue of curcumin, (1E,4E)-1,5-bis(2,3-dimethoxyphenyl)penta-1,4-dien-3-one, induced cancer cell H460 apoptosis via activation of endoplasmic reticulum stress signaling pathway.
Wang Y; Xiao J; Zhou H; Yang S; Wu X; Jiang C; Zhao Y; Liang D; Li X; Liang G
J Med Chem; 2011 Jun; 54(11):3768-78. PubMed ID: 21504179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
